15-Jun-2023
Download PDF
Aurobindo Pharma
We inform you that we received the enclosed advisory letter from National Stock Exchange of India Limited advising usto file an update in case of a delay in the timeline for completion of any proposed transaction disclosed to the stockexchanges and to avoid recurrence of such lapses.
Ask Value Research 
Mutual Fund Insight turns 24! 🎉 Get 2 FREE anniversary guides: The Right SIP + The Big Funds
New Process Alert 
Seems like you've uploaded a wrong QR code. Please upload the QR code downloaded from MF Central platform.
